Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance

High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries

(2011) Gregory A Roth et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Can We Improve Adherence to Preventive Therapies for Cardiovascular Health?

(2011) Judith K. Ockene et al.   CIRCULATION

Statin Use in Outpatients With Obstructive Coronary Artery Disease

(2011) Suzanne V. Arnold et al.   CIRCULATION

Promoting Global Cardiovascular Health

(2011) Valentin Fuster et al.   CIRCULATION

Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe

(2011) P. P. Cacoub et al.   HEART

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET

The “Million Hearts” Initiative — Preventing Heart Attacks and Strokes

(2011) Thomas R. Frieden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Full Coverage for Preventive Medications after Myocardial Infarction

(2011) Niteesh K. Choudhry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic Review of Guidelines on Cardiovascular Risk Assessment

(2010) Bart S. Ferket   ARCHIVES OF INTERNAL MEDICINE

Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data

(2010) Maaike SM van Mourik et al.   BMC Cardiovascular Disorders

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry

(2009) M. J. Alberts et al.   EUROPEAN HEART JOURNAL

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry

(2008) Patrice P. Cacoub et al.   ATHEROSCLEROSIS

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

(2008) A Cameron et al.   LANCET

Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey

(2007) K. Kotseva et al.   ATHEROSCLEROSIS